Test for early detection of cancer

Scientists have developed a panel of ten different biomarkers that can accurately indicate the presence of early operable-stage tumors in the body. These biomarkers can be present in very low levels but can still be used to identify even pre-cancerous conditions, before any systemic negative effects on the body occur. Currently, the results need to be validated on a larger sample size. If successful, blood analysis could become part of routine population screening for cancer.